Elucidation of human platelet function activation mechanism by SARS-CoV-2 and search for therapeutic method | Pandemic PACT Tracker

Key facts

Disease
COVID-19
Start & end year
2021
2024
Known Financial Commitments (USD)
$37,440
Funder
KAKENHI
Principal Investigator
Shuji Kawamoto Unspecified
Research Location
Japan
Lead Research Institution
Kyoto University
Research Priority Alignment
N/A

Research Category
Clinical characterisation and management
Research Subcategory
Disease pathogenesis
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable

Abstract

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Variant-derived SARS-CoV-2 spike protein does not directly cause platelet activation or hypercoagulability.